AMANDA FUHRER: Open Payments
NPI 1528074333 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 18 payments from 12 companies in 2025. Trend: 2023 $382 · 2024 $388 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $81 |
| UROGEN PHARMA, INC. | 3 | $70 |
| TOLMAR, INC. | 2 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Calyxo, Inc. | 2 | $41 |
| Endo USA, Inc. | 2 | $36 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| ABBVIE INC. | 1 | $21 |
Products named: AMS 700, JATENZO, JELMYTO, CVAC ASPIRATION SYSTEM, AVEED, PYLARIFY, ORGOVYX, Nubeqa.
Industry payments across IN — which companies pay providers there.
